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ABSTRACT
Objective: To provide an overview of non-
pharmacological interventions for behavioural and
psychological symptoms in dementia (BPSD).
Design: Systematic overview of reviews.
Data sources: PubMed, EMBASE, Cochrane Database
of Systematic Reviews, CINAHL and PsycINFO (2009–
March 2015).
Eligibility criteria: Systematic reviews (SRs) that
included at least one comparative study evaluating any
non-pharmacological intervention, to treat BPSD.
Data extraction: Eligible studies were selected and
data extracted independently by 2 reviewers.
The AMSTAR checklist was used to assess the
quality of the SRs.
Data analysis: Extracted data were synthesised using
a narrative approach.
Results: 38 SRs and 142 primary studies were
identified, comprising the following categories of non-
pharmacological interventions: (1) sensory stimulation
interventions (12 SRs, 27 primary studies) that
encompassed: acupressure, aromatherapy, massage/
touch therapy, light therapy and sensory garden; (2)
cognitive/emotion-oriented interventions (33 SRs; 70
primary studies) that included cognitive stimulation,
music/dance therapy, dance therapy, snoezelen,
transcutaneous electrical nerve stimulation,
reminiscence therapy, validation therapy, simulated
presence therapy; (3) behaviour management
techniques (6 SRs; 32 primary studies) and (4) other
therapies (5 SRs, 12 primary studies) comprising
exercise therapy, animal-assisted therapy, special care
unit and dining room environment-based interventions.
Music therapy was effective in reducing agitation
(SMD, −0.49; 95% CI −0.82 to −0.17; p=0.003), and
anxiety (SMD, −0.64; 95% CI −1.05 to −0.24;
p=0.002). Home-based behavioural management
techniques, caregiver-based interventions or staff
training in communication skills, person-centred care
or dementia care mapping with supervision during
implementation were found to be effective for
symptomatic and severe agitation.
Conclusions: A large number of non-pharmacological
interventions for BPSD were identified. The majority of
the studies had great variation in how the same type of
intervention was defined and applied, the follow-up
duration, the type of outcome measured, usually with
modest sample size. Overall, music therapy and
behavioural management techniques were effective for
reducing BPSD.
INTRODUCTION
Dementia is a neuropsychiatric syndrome
characterised by cognitive decline and pro-
gressive deterioration of daily function, often
associated with behavioural disturbances.
Strengths and limitations of this study
▪ Non-pharmacological interventions have gained
increasing attention in recent years as an alterna-
tive first-line approach to treat behavioural and
psychological symptoms in dementia (BPSD).
▪ The strength of this review is its extensive, com-
prehensive systematic search of studies that
investigated non-pharmacological interventions
for BPSD. It provides a compendium of the
types of non-pharmacological interventions,
including the component of each single interven-
tion, the dosage (when available) and the dur-
ation of the treatment.
▪ Primary studies were generally of limited sample
size; there was substantial variation in the
characteristics of the intervention and the
authors of primary studies reported different con-
ceptual frameworks, and sometimes broad, and
quite generic descriptions, of the interventions.
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The prevalence of dementia in older participants is
reported to be ∼6% worldwide1 and, with global popula-
tion ageing, it is expected to rise, although some recent
studies have suggested declining trends in dementia
frequency.2 Dementia presents a considerable burden to
families and caregivers and is becoming a major challenge
for all healthcare systems, as well as for society at large.3 4
Alzheimer’s disease (AD) is the most common form of
dementia in older people, accounting for 60% of cases.
Approximately ﬁve out of every six patients with
dementia, including those living at home, will develop
behavioural and psychological symptoms during the
course of the disease.5–8 Behavioural and psychological
symptoms in dementia (BPSD) are deﬁned as signs and
symptoms of disturbed behaviour, mood, thought or per-
ception.9 These disturbances, namely agitation, depres-
sion, elation, delusions and hallucinations, are strongly
correlated with each other.10 11 Twenty per cent of those
initially without symptoms will manifest them within
2 years of dementia diagnosis,12 whereas 50–80% of
those with clinically important symptoms remain agi-
tated for several months.13 In addition, at least 50% of
patients with dementia present with signiﬁcant BPSD on
a monthly basis.14 Agitation, together with depression,
hinder activities and relationships, cause feelings of
helplessness and distress in families and formal care-
givers15 and are strong predictors for poor quality of
life,16 as well as nursing home admission.17
Currently, options for treating BPSD include pharma-
cological and non-pharmacological therapies.18 19
Psychotropic medications are often used to reduce the
frequency and severity of BPSD, but in the majority of
patients, they provide only modest symptom control.20–22
A recent trial reported that the addition of citalopram
to psychosocial support signiﬁcantly reduced agitation
and caregiver distress.23 However, their adverse effects
are common and problematic, in particular the
increased risk of falls and fractures,24 stroke and even
mortality.25 In addition, there is some evidence that the
use of benzodiazepines to treat agitation in patients with
dementia may increase cognitive decline24 and may
expose patients to an immediate risk of injurious falls.26
Finally, memantine and cholinesterase inhibitors are
considered to be of very limited value to improve agita-
tion in participants with AD.27 28
In general, non-pharmacological interventions are
considered a preferable alternative to psychotropic
pharmacotherapy for treating BPSD.29 However, there is
conﬂicting evidence concerning the efﬁcacy and practi-
cality of non-pharmacological interventions to improve
BPSD, particularly agitation.9 30
The purpose of the present overview is to assess the
evidence supporting these non-pharmacological inter-
ventions with a view to providing a working compen-
dium for the non-drug management of BPSD.
The present overview updates the evidence on the
same theme gathered by a previous systematic overview
published in 2011.31
METHODS
This work is part of the Optimal Evidence-Based
Non-drug Therapies in Older People (ONTOP) project,
a work package of a European Union funded FP7
research named SENATOR (Software ENgine for the
Assessment & Optimization of drug and non-drug
Therapy in Older peRsons). The ONTOP aim is to
undertake a literature search of systematic reviews (SRs)
and provide clinical recommendations concerning
evidence-based non-pharmacological treatments of
several prevalent medical conditions affecting older
people, including delirium,32 33 pressure ulcers,33–35
falls,36 37 stroke and heart failure. A protocol that
describes the search strategy, screening and inclusion cri-
teria, has been previously published.38 Brieﬂy, to obtain
the evidence regarding the non-pharmacological inter-
ventions, we ﬁrst identiﬁed published SRs using a system-
atic search across several databases. After processing
eligible SRs, we identiﬁed and obtained primary studies
from these SRs to generate the compendium of non-
pharmacological interventions. In a subsequent work
will present the assessment of the body of evidence and
provide recommendations according to the GRADE
approach.38
Search strategy and inclusion criteria for systematic
reviews
The search sources included the Cochrane Database of
Systematic Reviews, PubMed, PsycINFO and CINAHL
(see online supplementary appendix 1). Two criteria
were considered for further evaluation of an abstract:
(1) a paper deﬁned as a review or a meta-analysis; (2)
the use of any non-pharmacological intervention to treat
behavioural disturbances in patients with dementia. The
publication years ranged from 2009 to March 2015.
Subsequently, full-texts of relevant abstracts were
obtained and screened to identify SRs of interest based
on (1) the use of at least one medical literature data-
base; (2) the inclusion of at least one primary study and
(3) the use of at least one non-pharmacological inter-
vention to treat behavioural disturbances in people aged
60+years.
We assessed the methodological quality of each SR
using the AMSTAR (A Measurement Tool to Assess
Reviews) instrument that contains 11 items.39 Final
grading of the methodological quality of each SR was
based on the overall score and reported as either ‘high’
(score≥8), ‘medium’ (score 4–7) or ‘low’ (score≤3).
Two reviewers independently assessed the quality of the
SRs, and disagreements were resolved by consensus.
Data extraction and management
From each SR, the following data were collected: the
publication year, the databases searched, the study popu-
lation, the non-pharmacological interventions, the
number of primary studies included, the outcome mea-
sures and the AMSTAR score. Pairs of reviewers inde-
pendently screened titles, abstracts and full texts of
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articles. Disagreements were resolved by discussion or,
where necessary, by consulting another author.
Outcome measures
We focused on reviews that considered BPSD, as a
primary outcome, measured by (1) multidomain scales
(eg, Neuropsychiatric Inventory (NPI), Brief Psychiatric
Rating Scale, BPRS), (2) scales speciﬁc to agitation (eg,
Cohen-Mansﬁeld Agitation Inventory, CMAI) and (3)
scales speciﬁc to depression or anxiety (eg, Cornell
Scale for Depression in Dementia, CSDD).
Inclusion criteria for primary studies and assessment
From the included SRs, we obtained any experimental
comparative study, either randomised or non-randomised,
that investigated any non-pharmacological intervention to
treat BPSD in older patients. Observational studies or
before–after studies, with historical controls, were excluded.
As outlined in our protocol, we extracted data from
primary studies to perform meta-analyses and heterogen-
eity was addressed using the Cochrane Collaboration
approach.38
Risk of bias assessment and grading the quality
of evidence
We used the Cochrane Collaboration method to evaluate
the risk of bias. The domains considered were random
sequence generation, allocation concealment,40 blinding
of participants, personnel, or outcome assessor,40 incom-
plete outcome data,41 selective reporting42 and other
potential biases (eg, balance in baseline characteristics).
The overall quality of evidence was assessed using the
GRADE (Grading of Recommendations, Assessment,
Development and Evaluation) methodology that takes
into account the risk of bias, consistency of results across
the studies, precision of the results, directness and likeli-
hood of publication bias.43 Results regarding the risk of
bias assessment, and grading the quality of evidence, will
be provided in a companion paper.
RESULTS
Our search strategy identiﬁed 4392 abstracts of which
2549 were duplicates and were subsequently removed.
After abstract screening, 67 records were identiﬁed for
full-text assessment. Of these, 38 reviews were included
in this overview. From these SRs, we obtained 142
primary studies from which we abstracted details of the
non-pharmacological interventions. Figure 1 shows the
study screening process. Table 1 depicts the basic
characteristics of the included SRs. The characteristics of
relevant primary studies are reported in online
supplementary appendix 2 as electronic tables (etable).
The AMSTAR evaluation are summarised in online
supplementary appendix 3.
The interventions in this overview were classiﬁed
according to the following categories: (1) sensory stimu-
lation interventions that encompass acupuncture, aroma-
therapy, massage therapy, light therapy, sensory garden
intervention, cognitive stimulation, music/singing and
dance therapy, snoezelen and transcutaneous electrical
Figure 1 Study screening
process.
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Table 1 Characteristics of included systematic reviews/meta-analyses
Author (year) Databases searched Population
Non-pharmacological
intervention Primary studies Outcome
Aguirre 2013 MEDLINE, Embase, Cinahl,
PsycINFO, the Cochrane
Library, Lilacs, trial registers,
grey literature
Participants who had a
diagnosis of dementia
(Alzheimer’s disease,
vascular dementia mixed
Alzheimer’s and vascular
dementia, other types of
dementia), including all levels
of cognitive impairment
Cognitive stimulation 15 RCTs Mood, quality of life, well-being,
ADL, communication, behaviour,
neuropsychiatric symptoms and
social interaction
Alves 2013 MEDLINE, PsycINFO,
Cochrane Library, EMBASE,
metaRegister of Clinical Trials,
OVID all, EBM Reviews
Patients diagnosed with
Alzheimer’s disease (without
mild cognitive impairment,
mixed Alzheimer’s disease,
vascular dementia, and other
types of dementia such as
frontotemporal dementia or
dementia with Lewy bodies)
Memory-training
program; attention-
stimulating activities;
computerized ‘cognitive
training’
4 studies Cognitive functioning; ADL;
memory Symptoms; finger
tapping test; depressive
symptoms; QoL; reaction time;
screening of mental status;
neuropsychiatric symptoms
Bernabei 2013 MEDLINE, Embase, PsycINFO Elderly patients affected by
dementia or psychiatric
disorders
Animal-assisted
interventions
10 studies on BPSD
(3 case–control and 7
repeated measures
design)
Any psychiatric disorder
Blake 2013 PubMed, Science Direct, the
Cochrane Library and Web of
Knowledge
Adults diagnosed with
dementia who have
depressive symptoms
Reminiscence group
therapy
4 studies Change in level of depressive
symptoms
Carrion 2013 MEDLINE, EMBASE, PASCAL,
the Cochrane Library, National
Guidelines Clearinghouse, Trip
database, HEALTHSTAR,
CINHAL and PsycINFO
Older people diagnosed as
having Alzheimer’s disease
or probable Alzheimer’s
disease
Cognition-oriented care
approaches: 1.Reality
orientation; 2. Skills
training
Reality orientation:
9 RCTs;Skills training:
8 RCTs
Cognitive function; behavioural
symptoms and mood
Chaudhury
2013
MEDLINE, CINAHL, Ageline,
Web of Science, and Simon
Fraser University library
catalogue
Long-term facility residents
with dementia
Supportive dining
environment
21 studies included:
light therapy (1 study);
music therapy
(3 studies)
Physiological and
sociopsychological aspects of
dining, including caloric intake,
enjoyment in eating and social
interaction
Collet 2010 MEDLINE, PsycINFO and
PubMed
Nursing home patients
suffering from either somatic
illness or dementia combined
with psychiatric disorders or
severe behavioural problems
Psychiatric care and
nursing home care
combination
8 RCTs Psychosis and depression,
increase in global functioning,
behaviour disorders, cognition
and ADL
Continued
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Table 1 Continued
Author (year) Databases searched Population
Non-pharmacological
intervention Primary studies Outcome
Eggenberger
2013
MEDLINE, AMED, EMBASE,
PsycINFO, CINAHL, The
Cochrane Library, Gerolit, Web
of Science
People with dementia;
professional and family
caregivers
Communication skills
training by means of
face-to-face interaction
12 RCTs QoL, social interactions
Forbes 2014 MEDLINE, EMBASE, the
Cochrane Library, CINAHL,
PsycINFO, LILACS+several
Registries, proceedings+other
sites
People with dementia Light therapy 5 studies met the
inclusion criteria—only
3 were included in the
analyses because of
inappropriate reported
Sleep, behaviour, mood, and
cognitive disturbances
associated with dementia
Forrester 2014 MEDLINE, EMBASE, the
Cochrane Library, CINAHL,
PsycINFO, LILACS+several
Registries, proceedings+other
sites
People with dementia Aromatherapy 2 RCTs Agitation, behavioural symptoms,
quality of life and adverse effects
Fung 2012 MEDLINE, CINAHL, Cochrane
Library, PsycINFO, Social
Sciences Citation Index,
SCOPUS
Participants with dementia Aromatherapy 11 studies (5 RCTs;
6 controlled trials)
Behavioural problems
Gonzalez 2014 MEDLINE, AMED, CINAHL, ISI
Web of Knowledge, Embase
and Scopus
People with dementia Sensory gardens and
horticultural activities
2 RCTs Agitation levels; cognitive status
Guzman-Garcia
2013
MEDLINE, AgeInfo, EBM
Reviews EBSCO-CINAHL,
EMBASE, ISI Web, LILACS,
SCOPUS ZETOC; reference
lists; EthOS-Beta; ACER;
Google;+
People with dementia living
in long-term care homes
Dance movement
therapy; dance therapy;
Psychomotor
dance-based; Social
dancing
10 studies (1 RCT) Not specified
Kiepe 2012 MEDLINE and PsycINFO Patients with mental illness Dance therapy 1 study (RCT) for
dementia
Any physical and mental
outcomes
Kim 2012 MEDLINE, CINAHL, ProQuest
Medical Library, and Cochrane
and OT
Persons with dementia Occupational therapy 9 studies Behavioural problems and
depression
Kverno 2009 MEDLINE, CINAHL, PsycINFO,
EMBASE
Individuals diagnosed with
advanced dementia
Any non-pharmacological
intervention
460 primary studies Neuropsychiatric symptoms
Lai 2009 MEDLINE, The Cochrane
Library, EMBASE, PsycINFO
and CINAHL
Patients with a confirmed
diagnosis of dementia or
Alzheimer’s disease or
related disorders
Special care units 8 non-randomised
studies (0 RCT)
Behavioural problems, mood,
use of restraints and
psychotropic medication
Continued
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Table 1 Continued
Author (year) Databases searched Population
Non-pharmacological
intervention Primary studies Outcome
Livingston 2014 MEDLINE; Web of Knowledge;
EMBASE; British Nursing
Index; the Health Technology
Assessment programme
database; PsycINFO; NHS
Evidence; System for
Information on Grey Literature
Participants with dementia Sensory, psychological
and behavioural
interventions
160 primary studies Agitation
McDermott
2013
MEDLINE, EMBASE,
PsycINFO, CINAHL, Cochrane
Library, Web of Science, J
Music Therapy, and Nordic
Journal of Music Therapy
Participants with dementia Music therapy 15 studies (6 RCTs;
4 non-randomised trials;
5 before–after studies
Behavioural, psychological
aspects, hormonal and
physiological changes, social
and relational aspects of music
therapy
Moniz-Cook
2012
MEDLINE, EMBASE, CINAHL,
PsycInfo and LILACS;+
People with dementia,
irrespective of its cause or
diagnostic subtype, with
reported BPSD or
‘behaviours that challenge’,
receiving support or
treatment from mental health
workers, care staff or family
or other informal caregivers
Formulation-led
individualised
interventions targeting
reduction in the
person’s distress and/or
resolution of the
caregivers’
management difficulties
18 trials Challenging behaviours (eg,
verbal and physical aggression,
restlessness) and mood
(depression).Changes in
caregiver self-report of reaction
to challenging behaviours.
Moyle 2013 MEDLINE, CINHAL, PsycINFO,
Cochrane Library, Scopus, Web
of Science, Health Reference
Center Academic
Older people with dementia: Massage therapy Of 13 studies identified
only 1 satisfied the
quality of the inclusion
criteria
Agitated behaviour
O’Neill 2011 MEDLINE, the Cochrane
Library, PsycINFO
Adults with mild, moderate, or
severe dementia
Non-pharmacological
treatments
28 systematic reviews Behavioural symptoms of
dementia
Olazaran 2010 MEDLINE, PsycINFO, CINAHL,
Embase, Lilacs and the
Cochrane Dementia and
Cognitive Improvement Group
Specialized Register
People with Alzheimer’s
disease and related disorders
Any non-pharmacological
intervention
213 Cognition; institutionalization;
ADL; behaviour; mood; QoL;
psychological well-being
Padilla 2011 MEDLINE, the Cochrane
Library, AgeLine, CINAHL,
PsycINFO, EMBASE, and
HealthSTAR, OT Seeker, and
Allied and Complementary
Medicine+reference list
People with Alzheimer’s
disease and related
dementias
Environment-based
interventions;
multisensory
approaches; other
interventions
1 cross-overall trial
(environmental-based
intervention)
Performance, affect and
behaviour
Continued
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Table 1 Continued
Author (year) Databases searched Population
Non-pharmacological
intervention Primary studies Outcome
Potter 2011 MEDLINE, EMBASE, CINAHL,
PsycINFO, AMED, the
Cochrane Library, the UK
National Research Register,
Current Controlled Trials
Older people with dementia Strength and flexibility;
strength and balance
Tai Chi classes sitting
and standing; walking;
stretching; seated
exercises; balance
training; endurance;
aerobic training
13 RCTs Physical functioning, quality of
life anddepression
Robinson 2011 MEDLINE; EBM reviews;
AMED; BNI; CINAHL; EMBASE
Not specified Acupressure 1 RCT (of 71
acupressure studies)
Any outcome
Salami 2011 MEDLINE, EMBASE and the
Cochrane Central Register
People with Alzheimer’s
disease
Any treatment option for
sleep disturbance not
attributable to other
clinical conditions
9 RCTs Sleep disturbance
Seitz 2012 MEDLINE, EMBASE,
PsycINFO, the Cochrane
Library and Google Scholar
People with dementia Any
non-pharmacological
intervention
40 studies Neuropsychiatric symptoms
Subramaniam
2012
MEDLINE, PsycINFO, CINAHL,
the Cochrane Library, EMBASE
and Web of Knowledge
People with dementia Reminiscence therapy 5 RCTs Psychosocial benefits
Thune-Boyle
2012
MEDLINE, EMBASE,
PsycINFO
People with dementia Exercise therapy 2 RCTs Behavioural and psychological
symptoms
Ueda 2013 MEDLINE, CINAHL, PsycINFO People with dementia Music therapy 18 of 20 studies
considered agitation
or anxiety (9 CCT;
9 RCTs)
Behavioral and psychological
symptoms; ADL; cognitive
function
Vasionytė 2013 JSTOR, EBSCO, ERIC,
SCIRUS, MEDLINE, PsycINFO,
Cochrane Library and
ProQuest, the journal
databases SAGE PUB and
Cambridge journals
Patients with dementia Music therapy 3 RCTs Affective, behavioural, cognitive
and physiological outcomes
Vasse 2010 PubMed, PsycINFO, Web of
Science and the Cochrane
library
People with dementia A walking program
combined with
conversation, group
validation therapy, life
review programs,
cognitive stimulation
therapy, activity therapy
and staff education
9 RCTs Communication between
residents with dementia and care
staff; neuropsychiatric symptoms
of residents with dementia.
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Table 1 Continued
Author (year) Databases searched Population
Non-pharmacological
intervention Primary studies Outcome
Wall 2010 MEDLINE, CINAHL, PsycINFO Older people with dementia Music therapy 4 RCTs Behaviour and well-being
Whear 2014 MEDLINE, PsycINFO, Embase,
HMIC, AMED; Cochrane
Library; CINAHL; British
Nursing Index; ASSIA; Social
Science Citation Index; EThOS;
Social Care Online and
OpenGrey November 2012.
Elderly residents with
dementia
Mealtime interventions
categorized into four
types: music, changes
to food service, dining
environment alteration,
and group conversation
11 studies (7 time
series repeated
measures; 3 pre-post
study design; 1
controlled clinical trial)
Behavioural symptoms (anxiety,
agitation, aggression)
Woods 2012 MEDLINE, the Cochrane
Library, EMBASE, PsycINFO,
CINAHL and LILACS, ongoing
trial databases and grey
literature sources
People with dementia and
their caregivers
Cognitive stimulation 15 RCTs Cognitive functioning; mood;
QoL; ADL; behavioural
symptoms; neuropsychiatric
symptoms
Yu 2009 MEDLINE (PubMed), CINAHL,
PsycINFO, and the Cochrane
Library
People with early-stage
Alzheimer’s disease and
dementia
Cognitive training 7 RCTs Any dementia symptoms in
early-stage Alzheimer’s disease
and related dementia.
Zimmerman
2013
MEDLINE, EMBASE, the
Cochrane Library, the
Cumulative Index to Nursing
and Allied Health Literature,
AgeLine, and PsycINFO
People with dementia in
nursing homes and other
residential long-term care
settings
Effective characteristics
of residential long-term
care
14 studies: 4
prospective cohort
studies, 9 RCTs, 1
non-randomized
controlled trial
Health and psychosocial
outcomes
ADL, activities of daily living; QoL, quality of life; RCT, randomised controlled trial.
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nerve stimulation (TENS) therapy; (2) cognitive/
emotion-oriented interventions that include reminis-
cence therapy, validation therapy, simulated presence
therapy (SPT); (3) behavioural management technique
and (4) other interventions, such as exercise therapy,
pet-therapy and special care unit.
Sensory stimulation interventions
Shiatsu and acupressure
Only one SR was identiﬁed. Robinson 201144
(AMSTAR=7) investigated the evidence available for
shiatsu and acupressure in BPSD. Shiatsu is a form of
complementary medicine primarily developed in Japan,
which employs gentle manipulations, stretches and pres-
sure with the ﬁngers, elbows, knees and feet.
Acupressure is similar, but exerts pressure for longer on
speciﬁc meridian points according to traditional
Chinese medicine or acupoints of the human body in
order to ‘balance energy ﬁelds’.
The authors identiﬁed 40 RCTs, 8 controlled clinical
trials, 5 crossover trials, 6 within-participants studies,
1 observational study, 10 uncontrolled studies and 1 pro-
spective study. Only one randomised trial (n=133 partici-
pants) using acupressure in dementia participants was
relevant for our assessment.45 The authors reported that
agitation, aggression and physically non-aggressive
behaviour all declined signiﬁcantly in demented
participants.
Aromatherapy
Aromatherapy is proposed as a complementary interven-
tion, to treat a wide-range of health problems, including
lack of sleep and behavioural symptoms for people with
dementia.46 Aromatherapy is based on the use of plant
products or aromatic plant oils to produce essential oils
and blends of aromatic compounds. Aromatherapy can
be delivered through massage or topical application,
inhalation and water immersion.
Our systematic search identiﬁed three SRs that consid-
ered aromatherapy as an intervention to treat agitated
behaviours and other outcomes in patients with demen-
tia. The AMSTAR scores ranged from 6 to 8 across the
reviews. The range of included primary studies varied
from 4 to 13.29 47 48
The most recent SR was a Cochrane review,48 which
had the highest AMSTAR quality score (8). The review
included only randomised trials and launched its last
search strategy in January 2013. Seven studies with 428
participants were identiﬁed. The types of interventions
included lavender-based (four studies49–52), Melissa-
based (two studies53 54) and lemon balm oil (1 study)
aromatherapy. However, only two of these had usable
data for pooling. The ﬁrst study (n=71) reported a favour-
able treatment effect on measures of agitation (MD
−11.1, 95% CI −19.9 to −2.2) and behavioural symptoms
(MD −15.8, 95% CI −24.4 to −7.2), whereas the second
trial (n=63) did not detect any difference in agitation
(MD 0.00, 95% CI −1.36 to 1.36) or behavioural
symptoms (n=63, MD 2.80, 95% CI −5.84 to 11.44). The
review authors remarked that the published studies used
different scales to assess the behavioural symptoms and
were limited in sample size and methodological quality,
particularly because of selective reporting bias.
The second review by Seitz et al29 consisted of any non-
pharmacological interventions, including aromatherapy,
to treat outcomes relevant to patients with dementia.
The review reported data in a narrative way and cited
only one study of aromatherapy,53 which was also
included in the Cochrane review above.48 The review
received an AMSTAR score of 6.
The third study was a review by Fung et al,47 which
considered only aromatherapy as a non-pharmacological
intervention. The review was judged to have moderate
methodological quality (AMSTAR score=6). After per-
forming a comprehensive search in several electronic
databases, 11 studies were identiﬁed, with a total of 405
patients in different settings, including long-term care
(LTC) homes, clinical centres and general and old age
psychiatry. In addition to the trials included in the above
cited Cochrane review, the review by Fung et al47
included one randomised trial55 which was excluded in
the Cochrane review because the route of administration
was not reported and there was no mention of the type
of the aromatherapy, in addition to ﬁve controlled clin-
ical trials.56–60 Moreover, the Fung et al review47 did not
include the two trials49 51 61 that were evaluated in the
Cochrane review. The controlled clinical trials could not
be included in a meta-analysis because of heterogeneity.
The review highlighted the methodological limitations
of the studies and reported promising results of aroma-
therapy. Online supplementary etable 1 describes the
type of interventions, the outcomes and the results of
the primary studies included in the aromatherapy
reviews.
Massage therapy
Massage and touch therapy have been proposed as non-
pharmacological interventions to be used in dementia to
offset manifestations of cognitive decline and beha-
vioural disturbances, including related psychological
problems, such as depression and anxiety, and to
improve quality of life.62
Two reviews were identiﬁed. The ﬁrst was a Cochrane
review63 that was included in the review by O’Neil et al.31
This review assessed the efﬁcacy of massage and touch
therapy for the treatment of BPSD. Its last search strat-
egy was launched in 2006. The aim of the overview was
to evaluate the effects of a range of massage and touch
therapies on conditions associated with dementia, such
as anxiety, agitated behaviour and depression, to identify
any adverse effects and to provide recommendations for
future trials. The review considered only randomised
trials. The primary outcome measures were changes in
the frequency and severity of various types of agitated
behaviour, as observed by staff or investigators (short-
term and long-term using any rating method), and the
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emotional well-being and the quality of life of the
patients (rated by staff, investigators and/or patients
themselves using any method).
Remington (2002)64 assessed the effect of music and
massage in 68 nursing home residents with dementia
(AD, multi-infarct dementia or senile dementia). The
participants were randomly allocated into four groups:
calming music, hand massage, simultaneous calming
music and hand massage and no intervention. The inter-
vention lasted 10 min and was given to each patient once.
The efﬁcacy of treatment on ‘agitation level’ was evalu-
ated with a modiﬁed version of the CMAI administered
by trained research assistants who were blinded to treat-
ment allocation when possible. The method of randomi-
sation was unclear and to conceal allocation, sealed
envelopes, without further explanation, were used.
However, patients could have been excluded after alloca-
tion (if they had a CMAI score of 0 at baseline) and con-
sequently the study was considered to have high risk of
selection bias.
The trial found that agitated behaviour decreased,
more so in the group receiving hand massage than in
the group receiving no treatment. This treatment effect
was consistently found, compared to baseline, for mea-
surements taken during treatment, immediately after
treatment and 1-hour after treatment, and it was practic-
ally identical among the three groups receiving treat-
ment (hand massage, calming music or both). The
mean agitation score was in favour of massage therapy
immediately after treatment (MD 7.83 (4.30 to 11.36))
and 1-hour after treatment (MD 12.12 (6.58 to 17.66)).
The second review by Moyle et al65 conducted a search
in 10 databases in October 2011. The authors identiﬁed
13 studies that evaluated massage therapy for the treat-
ment of behavioural disturbances in patients with
dementia, but only one study with a high methodo-
logical score, using the Validity Rating Tool, was identi-
ﬁed. The included study, performed by Holliday-
Welsh,66 was a prospective before–after study in which
52 participants (39 women and 13 men; mean age
90 years) from two skilled nursing facilities in
Northeastern Minnesota, USA, were enrolled. Patients
were cognitively impaired and had a history of agitated
behaviour conﬁrmed by the facility staff. The interven-
tion consisted of a 10-min to 15-min massage of the
upper extremities (including the head, shoulders and
hands), undertaken by a physical therapy assistant,
during a 1-hour period identiﬁed by caregivers as the
time the participant was usually most agitated (indivi-
dualised for each participant). The outcomes of interest
were assessed with a scale that used the ﬁve behavioural
symptoms from the minimum data set; (1) wandering;
(2) verbally abusive behavioural symptoms; (3) physically
abusive behavioural symptoms; (4) socially inappropri-
ate/disruptive behaviour and (5) resistance to care.
Methodologically, the study was considered at high
risk of selection and performance bias given the study
design and the nature of the intervention. In addition, it
was unclear whether the outcome assessor was blinded.
Massage therapy was signiﬁcantly associated with
improvement for four of the ﬁve outcomes examined,
including wandering (0.38 vs 0.16, p<0.001), verbally agi-
tated behavioural symptoms (0.59 vs 0.49, p=0.002),
physically agitated behavioural symptoms (0.82 vs 0.40,
p<0.001) and resistance to care (0.10 vs 0.09, p=0.022).
Online supplementary etable 2 describes the type of
interventions, the outcomes and the results of the
primary studies included in the massage therapy reviews.
Light therapy
Rest-activity and sleep-wake cycles are controlled by the
endogenous circadian rhythm generated by the supra-
chiasmatic nucleus (SCN) of the hypothalamus.
Degenerative changes in the SCN appear to be a bio-
logical cause of circadian rhythm disturbances in people
with dementia. In addition to the internal regulatory
loss, older people (especially those with dementia)
experience a reduction in sensory input, due to less
visual sensitivity to light and less exposure to bright
environmental light. Evidence suggests that circadian
rhythm disturbances may be reversed by stimulation of
the SCN with light.67
Four reviews considered the use of bright light
therapy to treat behavioural problems in patients with
dementia.
The ﬁrst was a Cochrane review67 (AMSTAR=10) with
the aim of evaluating the effectiveness of light therapy
to improve cognition, activities of daily living (ADLs),
sleep, challenging behaviour and psychiatric distur-
bances associated with dementia. The search strategy
was launched in January 2014. The included studies
were randomised trials that compared any bright light
therapy, including dim red light or dim, low-frequency
blinking light <300 lux, to usual care. The primary
outcome measures included cognition (global or single
domain, eg, memory), ADLs, sleep-wake disturbances,
challenging behaviour (eg, agitation), psychiatric distur-
bances (eg, depression) and adverse effects. Secondary
outcomes were rates of institutionalisation and overall
cost of care. The authors identiﬁed 11 studies, but stated
that three of the studies could not be included in the
analyses either because the data were insufﬁcient or
could not be retrieved from the trial authors. Only four
of the included studies considered challenging behav-
iour as an outcome, but the sample sizes were limited
and the outcome measures were not the same across the
studies.68–71 A meta-analysis of challenging behaviour,
however, was performed and no substantial heterogen-
eity was found, although the results were not statistically
in favour of bright light therapy.
The second review aimed to identify which non-
pharmacological interventions were most effective for
BPSD in LTC.29 Only two studies68 69 were included in
the review (which were already included in the Forbes
review67), but were not assessed in detail. The review
received four points in the AMSTAR rating system.
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The third review72 aimed to assess the role of physical
environment in supporting person-centred dining in
LTC. Only one study that evaluated the effect of
ambient bright light in activity and dining areas among
institutionalised people with dementia was identiﬁed.73
This study was not included in the previous two reviews.
The fourth review74 that addressed the effectiveness of
environment-based interventions for people with AD or
dementia identiﬁed a cluster-unit crossover trial.75 The
trial was conducted in two geriatric units in a state-oper-
ated psychiatric hospital and in a dementia-speciﬁc resi-
dential care facility in Oregon, USA, and enrolled 66
older adults with dementia to evaluate the effectiveness
of ambient bright light therapy, delivered through a
high-intensity, low-glare lighting system installed in the
public areas of study units at both sites, at reducing
depressive symptoms. Each lighting condition was pro-
vided for multiple 3-week periods in a predetermined
sequence. The CSDD was used to assess depressive symp-
toms. Results did not support the use of ambient bright
light therapy as a treatment for depressive symptoms in
people with dementia.75 Online supplementary etable 3
describes the type of interventions, the outcomes and
the results of the primary studies included in the light
therapy reviews.
Sensory garden and horticultural activities
Whear 2014 76 (AMSTAR=7) investigated the impact of
gardens and horticultural therapy on the mental and
physical well-being of residents with dementia, in
nursing homes and specialised dementia care facilities.
This approach uses either ‘sensory’ gardens to stimulate
the ﬁve senses (sight, vision, hearing, smell and touch),
or plants and plant-related activities to improve well-
being (horticultural therapy or therapeutic horticul-
ture). Eighteen studies were identiﬁed: ten were quanti-
tative studies (two RCTs (n=34), six pre-post studies, one
crossover study, one prospective cohort study), seven
qualitative and one used mixed methods. In one of the
RCTs,77 there was a non-statistically signiﬁcant decline in
verbal and physical aggression and non-verbal aggres-
sion, and total CMAI score (Online supplementary
etable 4).
Gonzalez et al78 (AMSTAR=3) examined the effects of
sensory garden and horticultural activities in dementia
care. Sixteen studies were identiﬁed, including 2 RCTs
(n=149), one of which was cluster randomised, 11
pre-post studies, 2 case studies and 1 survey. In the
smaller of the two RCTs,79 verbal agitation signiﬁcantly
decreased in the outdoor horticultural group compared
to the indoor horticultural group, while in the larger
trial, the effect of participants in the horticultural group
did not differ from the traditional activity group.
(Connell et al79 was included in both SRs.76 78)
Online supplementary etable 4 describes the type of
interventions, the outcomes and the results of the
primary studies included in the sensory garden and
horticultural activities reviews.
Music and dance therapy
Music therapy is the application of music and/or its ele-
ments (melody, rhythm, harmony, sound) by a qualiﬁed
musical therapist, in order to support and stimulate
various aspects of cognitive, emotional, social and phys-
ical needs, such as expression, communication, learning
and forming relationships. Participants can passively
listen to music or actively participate by singing, playing
an instrument or moving. Dance therapy is a psycho-
therapeutic intervention that uses movement to ‘further
the emotional, cognitive, physical and social integration
of the individual’.80
Six SRs that evaluated music therapy,29 81–85 and one
review that assessed live singing to people affected with
dementia,80 were identiﬁed.
The number of included primary studies in the
reviews varied from 3 to 18, and the AMSTAR scores of
the reviews ranged from 2 to 7.
The review by Ueda 201382 received the highest score
(AMSTAR=7) and included nine randomised trials and nine
controlled clinical trials that evaluated one music-related
experience or a combination of music-related experiences,
such as singing, listening, performing, rhythmic exercising
and improvising. Uncontrolled before-and-after studies and
case studies were excluded.
Participants were allocated to music therapy (mean of
36 min/day, 2–3 days/week for 10 weeks (range 1 day to
11 months)) or usual care for BPSD assessment. The
music therapy comprised listening,86–93 moving/
dancing,86 88 89 94–97 singing/playing a musical instru-
ment86 88 89 92 93 95 96 98–102 and in some occasion was
administered in combination with exercise103 and remin-
iscence therapy.89 99 101
Music therapy was effective in reducing behavioural
symptoms (6 RCTs+5 CTs; 397 participants) (SMD=
−0.49 (95% CI −0.82 to −0.17)), despite a moderate
and statistically signiﬁcant heterogeneity (I2=58%,
p=0.009). The same intervention achieved a statistically
signiﬁcant reduction on depression (4 RCTs+5 CTs;
250 participants) (SMD=−0.32 (95% CI −0.68 to
−0.04); I2=44%, p=0.08) and anxiety (SMD −0.64, 95%
CI −1.05 to −0.24; I2=55%; eight studies; 258
participants).
Whear et al85 investigated the effectiveness of mealtime
interventions, including music, on BPSD in people with
dementia in residential nursing homes or care homes.
Eleven studies were identiﬁed: one controlled trial,
three before/after studies and seven repeated measure
time series studies. The results of the studies were
described narratively. One before/after study with 22
participants found that music played at mealtime
improved physical and verbal, aggressive and non-
aggressive, behaviour using the CMAI.
Seitz et al29 (AMSTAR=6) identiﬁed 40 RCTs of non-
pharmacological interventions, of which 3 studies with
133 participants96 97 104 evaluated music therapy for
BPSD of dementia in LTC facilities. Owing to the hetero-
geneity of the studies (study design, patient populations,
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interventions, treatment duration and outcomes mea-
sured), the authors did not perform a meta-analysis.
The behavioural outcome was measured either with a
modiﬁed CMAI, Behavioural Pathology in Alzheimer’s
Disease Rating Scale (BEHAVE-AD) or the NPI. In one
study, the music therapy was performed with movement,
in a group, for 30 min, twice/week for 4 weeks.97 In a
second study, the music intervention lasted 30 min, 3
times/week for 6 weeks.104 And in a third trial, the dur-
ation and frequency of individual sessions were not spe-
ciﬁed, but the therapy lasted 14 weeks.96 Two of the
three studies employing music found a statistically sig-
niﬁcant difference between treatment and control
groups, but all three were at risk of randomisation bias
and two had unclear bias of incomplete outcome data.
All the studies were included in Ueda’s review.82
The review by McDermott et al81 (AMSTAR=4)
searched MEDLINE, EMBASE, PsycINFO, CINAHL, the
Cochrane Library, Web of Science, Journal of Music
Therapy and Nordic Journal of Music Therapy and identiﬁed
18 studies of which 6 were RCTs (the remaining were
non-randomised controlled studies (n=4), before-and-
after studies (n=5) and qualitative and mixed-method
studies (n=3)). Two trials96 100 and the case–control
study104 were already included in the reviews described
above.29 82 Three RCTs (n=165), two of which were
carried out by the same group, measured BPSD using
either the NPI or BEHAVE-AD. In one trial, the music
therapy (patients and music therapist play musical
instruments to express emotions and interact) was per-
formed for 30 min, 3 times/week for 1-month, followed
by a 1-month interruption, over 6 months (Raglio 2010).
In another study by the same group, the music therapy
(singing and body movement with music to stimulate
communication) was administered for 30 min, 30 times
over 16 weeks.96 In the third trial, the therapy was exe-
cuted for 30 min, 3 times/week for 6 weeks (Svansdottir
2006). McDermott et al concluded that evidence for
reduction of behavioural disturbance was consistent, but
there were no high-quality longitudinal studies that
demonstrated long-term beneﬁts of music therapy. Of
note, ﬁve of the RCTs included in the review were not
included in the review by Ueda et al.82
Unlike the previous review, Vasionyte˙ and Madison83
(AMSTAR=4) provided a meta-analysis of the effects of
music interventions (median=8 weeks; range 2–53
weeks) in patients with dementia, differentiating
between different types of interventions (listening, active
music therapy, recorded music, live music, selected
music, individualised music, classical/relaxation music,
popular/native music and group and individual
interventions). This SR included 18 studies comprised
of 6 RCTs,87 90 105–108 6 CCTs 88 91 98 102 109 and 6
pre–post-test studies. The outcomes evaluated were
behaviour (measured with the CMAI, NPI-Q,
Multidimensional Observation Scale for Elderly
Participants (MOSES), an agitation checklist or a behav-
ioural chart), affect, cognition and physiology. There was
no statistically signiﬁcant effect on behaviour (effect size
(ES) 1.16, 95% CI −0.65 to 2.98; 8 studies, n=217) or
affect (ES 0.38, 95% CI −0.56 to 1.32; 6 studies, n=109),
while cognition (ES 1.56, 95% CI 1.11 to 2.01; 4 studies,
n=63) and physiology (ES 0.72, 95% CI 0.36 to 1.08; 4
studies, n=88) were affected. Three of the RCTs, and
four of the controlled trials, in this review, were also
included in Ueda et al.82
The review by Wall and Duffy84 included 13 studies
that were presented narratively. The review was of low
quality (AMSTAR score 2).
The review by Chatterton et al80 evaluated the efﬁcacy
of ‘live’ singing to people with dementia for cognitive,
behavioural, physiological and social outcomes. The
study received an AMSTAR score of 1.
An additional SR72 that aimed to assess the role of the
physical environment in supporting person-centred
dining in LTC identiﬁed four non-randomised studies,
with different designs, that evaluated the effect of music
on the incidence of agitated behaviours during meal-
times, among older adults with dementia, residing in
special care units (SCUs).110–113 The results of these
studies showed that playing music during mealtime
reduced the incidence of agitated behaviour.
Online supplementary etable 5a describes the type of
interventions, the outcomes and the results of the
primary studies included in the music therapy reviews.
Dance therapy
Two reviews evaluated dance therapy in patients with
dementia.114 115 The ﬁrst review’s objective was to evalu-
ate the evidence concerning dancing interventions in
physical and mental illnesses compared to other types of
interventions or non-speciﬁc interventions.115 The
review received 3 points in the AMSTAR scoring system
and identiﬁed 13 small studies reporting results from 11
randomised trials of which only one considered patients
with dementia. The trial that considered participants
with dementia included 29 participants (mean age
79 years, SD 7.7; 75% women) in a nursing home and
evaluated the efﬁcacy of dance and movement therapy
delivered in nine sessions, lasting 30 to 45 min each,
once-a-week.116 The outcome measures included the
word list savings score, the Clock drawing test (for visual
spatial ability), the Cookie Theft picture description task
from the Boston Diagnostic Aphasia test and the Nurses’
Observation Scale for Geriatric Patients (NOSGER). The
results did not show any important differences in favour
of dance therapy.
The second SR aimed to evaluate the effects of dance
(movement) therapy and ballroom dancing, compared
to usual care, for adults with physical and mental ill-
nesses.114 The review received only one point on the
AMSTAR Scale and identiﬁed only one study that investi-
gated the intervention in a population affected by
dementia116 and which was also included in the review
above.
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Snoezelen multisensory stimulation therapy
Snoezelen multisensory stimulation therapy (SMST)
comprises multiple stimuli and is aimed at stimulating
the primary senses of sight, hearing, touch, taste and
smell. The intervention is provided in specially designed
rooms, which provide diverse sensory-stimulating
effects/material including music, aroma, bubble tubes,
ﬁbre optic sprays and moving shapes projected across
walls. SMST was investigated by two reviews.29 31
The ﬁrst was an overview of reviews,31 and its evidence
for SMST was based on a Cochrane review that included
three studies.117 The inclusion criterion was any rando-
mised trial that assessed the efﬁcacy of SMST and/or
multisensory stimulation to treat people over 60 years of
age suffering from dementia. The outcomes of interest
included behaviour, mood, cognition, physiological
indices and client–carer communication, as well as short-
term effects measured during the sessions or postses-
sion, and longer term beneﬁts measured postinterven-
tion and at follow-up.
The three included primary studies evaluated a total
of 311 patients with dementia, aged 60 or older. The
ﬁrst was a randomised trial118 that compared eight stan-
dardised multisensory programmes with eight standar-
dised activity sessions. Both programmes were
implemented on a one-to-one basis, twice-a-week, with
each session lasting 30 min. Fifty participants (25
women, mean age 78) with a diagnosis of AD (N=33),
vascular dementia (N=7) or a mixed diagnosis (N=10)
were enrolled. The objectives of the trial were the imme-
diate effects of SMST on the behaviours of older people
with dementia, the carryover effects of SMST on mood
and behaviour to day-hospitals and home environments
and the maintenance effects of SMST on mood, behav-
iour and cognition over time. The effects of SMST on
behaviour were measured by INTERACT.119 The gener-
alisation effects were measured by three outcome mea-
sures: the carryover effect of day-hospitals was measured
with the General Behaviour and Community Skills sub-
scales of REHAB (Baker 1988); the carryover effect to
home, at midintervention and postintervention, was
measured with the Behaviour and Mood Disturbance
Scale (BMD) and the Behaviour Rating Scale (BRS) of
the Clifton Assessment Procedures for the Elderly
(CAPE). The maintenance effect (at the 1-month postin-
tervention follow-up) on behaviours and cognition were
measured by REHAB, BMD, the Cognitive Assessment
Scale (CAS) of CAPE and Mini-Mental State Examination
(MMSE). No signiﬁcant effects on any scale of behav-
ioural symptoms were found either immediately after
intervention or at 1-month follow-up.
The second study120 was a quasi-experimental pre-test
and post-test design with cluster randomisation per-
formed at a ward level, which compared a 15-month,
24-hour individualised care plan that was integrated with
SMST, with 15-month usual care. The study included
136 participants diagnosed with AD, vascular or mixed
dementia from three different countries (UK=94 day
patients, the Dutch sample=26 inpatients. Swedish
sample=16 inpatients). There was a signiﬁcant group dif-
ference in the mean baseline MMSE scores (data from
the UK and the Dutch only) between the SMST group
(9.4) and the control group (6.7) (p=0.01). All partici-
pants attended eight, 30-min sessions on a one-to-one
basis according to their group assignment. The sessions
were conducted by the same key workers throughout the
study period. The following outcomes measured the
short-term effects of SMST on behaviours: (1)
INTERACT (22-item) measured behaviours during the
sessions; (2) INTERACT (12-item) measured behaviours
10 min before and 10 min after the sessions and (3)
Behaviour Observation Scale for Intra-mural Psycho-
Geriatrics (GIP) measured behaviours that were video-
taped during the sessions in the Netherlands sample.
The study showed signiﬁcant effects on two behav-
ioural items of INTERACT during sessions: enjoying
oneself (MD=−0.74; 95% CI (−1.29 to −0.19); z=2.62,
p=0.01) and bored/inactive (MD=−0.56; 95% CI (−1.11
to −0.01); z=1.99, p=0.05). There were no longer term
treatment effects of the integrated SMST-care pro-
gramme on behaviour.
The third study121 122 assessed the effects of SMST
when integrated into 24-hour daily care on nursing
home residents with dementia. A total of 125 patients
with moderate or severe dementia and care dependency
were recruited from six old age psychiatry wards for
pre-test. A cluster randomised design was used to assign
the wards to either experimental (integrated SMST-care
programme) or control (usual activity) conditions.
Twelve old age psychiatry wards in six nursing homes
(out of 19 homes) were recruited to the study. At base-
line, 125 participants (woman 79%, mean age 84) were
recruited and were assigned to experimental or control
conditions according to the ward in which they stayed.
For the experimental group, participants were given a
stimulus-preference screening in 10 weekly one-hour ses-
sions to identify their preferred sensory stimuli.
Subsequently, individual SMST-care plans were develo-
ped for each participant based on their life history,
stimulus preference and discussions from multidisciplin-
ary conferences. Certiﬁed nursing assistants (CNAs)
used multisensory stimuli in the 24-hour care of the
experimental participants. Participants in the control
group were provided with individual usual care. A
minimum period of 3 months was used for experimental
and control conditions.
The short-term effects of the integrated SMST-care
programme on behaviours were measured using a modi-
ﬁed version of INTERACT, in which six items were
deleted and eight new items were added during
morning care sessions. The long-term effects of inte-
grated SMST-care programmes on behaviours, mood
and interaction were evaluated at the 18-month
follow-up using the eight items of GIP for apathy,
anxiety and disoriented behaviours, the Dutch version of
CMAI for agitated behaviours, physically non-aggressive
Abraha I, et al. BMJ Open 2017;7:e012759. doi:10.1136/bmjopen-2016-012759 13
Open Access
group.bmj.com on May 12, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
behaviour and verbally agitated behaviours and the
Cornell Scale for Depression for depressive symptoms.
In terms of behavioural disturbances, when compared to
the control, the 24-hour integrated SMST-care pro-
gramme122 showed a signiﬁcant effect on two behav-
ioural items of INTERACT during sessions: enjoying self
(MD=−0.74; 95% CI (−1.29 to −0.19); z=2.62, p=0.01)
and bored/inactive (MD=−0.56; 95% CI (−1.11 to
−0.01); z=1.99, p=0.05). There were no longer term
treatment effects of the integrated SMST-care pro-
gramme on behaviour. In terms of mood, there were sig-
niﬁcant improvements in one mood item of INTREACT
during sessions: the SMST group was happier and more
content than the control group (MD=−0.84; 95% CI
(−1.39 to −0.29); z=2.98, p=0.003). There were no sig-
niﬁcant effects of the 24-hour integrated SMST at postin-
tervention. The fourth review scored 6 in the AMSTAR
evaluation and investigated different non-
pharmacological interventions including SMST for the
treatment of BPSD.29 The review identiﬁed only one
study that was included in the above cited review.122
Online supplementary etable 6 describes SMST-based
interventions, outcomes and results of the primary
studies included in the reviews.
Transcutaneous electrical nerve stimulation
TENS is a simple, non-invasive, non-pharmacological
intervention commonly used for pain control123 and
occasionally for neurological and psychiatric conditions
such as drug/alcohol dependency, headaches and
depression.31 TENS consists of attaching electrodes to
the skin and applying an electrical current, whose fre-
quency can vary from low (<10 Hz) to high (>50 Hz).
Two reviews were identiﬁed. One review that evaluated
current treatment options for sleep disturbance in AD
scored 3 in the AMSTAR evaluation.124 Different non-
pharmacological interventions were considered, includ-
ing bright light therapy, behavioural and multifaceted
interventions (combined increased daytime physical
activity and exercise, decreased daytime in-bed time,
daily sunlight exposure, structured bedtime routine and
decreased night-time noise and light) and TENS. For
the latter intervention, only one randomised trial of 19
nursing home residents was identiﬁed. The study did
not evaluate behavioural outcomes.
A Cochrane review that was included in O’Neil’s
review31 was also considered.125 The review was focused
only on RCTs that enrolled inpatients and outpatients of
any age (with or without caregivers), with a diagnosis of
dementia. The outcomes of interest included visual and
verbal short-term and long-term memory, semantic
verbal ﬂuency, circadian rest-activity rhythm, affect/
depression, level of independent functioning, adverse
effects and dropouts due to inefﬁcacy. The review identi-
ﬁed and included nine trials that were performed in
Japan and the Netherlands. The Dutch studies were per-
formed by the same group of authors.126–131 These
studies were randomised placebo-controlled trials, and
the participants were chosen from a group of 350–500
residents of a residential home for older people. The
age range of the participants was ∼70 to mid-90 years
and were mostly women (>80%). All participants met
NINCDS-ADRDA criteria for the clinical diagnosis of
probable AD; most participants had early AD, but some
had moderate AD. Participants generally had scores of
17 or less on the Hamilton Depression Rating Scale. All
included studies used a similar TENS protocol, except
the most recent one published in 2002, which addressed
cranial electrostimulation.
The remaining three publications were performed by
a group of authors from Japan and describe the results
of the same study.132 The study design was a double-
blind crossover and, in contrast to the Dutch studies,
participants were thought to have multiinfarct dementia
or AD and were selected on the basis of irregular sleep-
wake patterns in conjunction with nocturnal behaviour
disorders and/or dementia. Twenty-seven participants
completed the study. The intervention used a HESS-10
stimulator with rectangular pulse waveforms at a fre-
quency of 6–80 Hz, a pulse duration of 0.2 ms
maximum, 256 µAmps and an amplitude of 6–8 V. The
outcomes evaluated were sleep disorder, motivation,
behaviour disorder, intelligence, emotion, language,
neurological signs, subjective symptoms and activities of
daily life. All of these were rated on a ﬁve-point scale:
absence of the related symptom, 0; mildly disturbed, 1;
moderately disturbed, 2; markedly disturbed, 3 and
severely disturbed, 4. Of the nine studies, only three
could be included in a meta-analysis for a combined
total of 63 participants. Two of these studies were con-
ducted in the Netherlands, and one was conducted in
Japan. Results, however, were inconclusive. It should be
noted that none of the other studies mentioned adverse
effects, although it is unclear if adverse events were
monitored.
Online supplementary etable 7 describes TENS-based
interventions, outcomes and results of the primary
studies included in the reviews.
Cognitive/emotion-oriented interventions
Cognitive stimulation
Cognitive stimulation involves a variety of pleasurable activ-
ities, such as word games, puzzles, music, cooking, garden-
ing and discussing past and present events, and is usually
carried out by trained personnel with small groups of four
to ﬁve people. It lasts for 45 min, minimally 2 times/week.
It is based on Reality Orientation, which was developed in
the 1950s to counteract the confusion and disorientation
of older people during hospitalisations. Seven reviews
were identiﬁed.133–139
Woods 2012133 (AMSTAR score=10) was a Cochrane
review that identiﬁed 15 RCTs that used cognitive stimu-
lation for people with dementia. The authors stated that
most of the studies were of low quality, but that gener-
ally, investigators had taken measures to protect against
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the risk of allocation concealment bias. In a
meta-analysis of three trials140–142 (n=190 participants),
the intervention had no effect on problem behaviours
(SMD −0.14, 95% CI −0.44 to 0.17; I2=0%, p=0.57).
The review by Aguirre et al in 2013134 (AMSTAR
score=5) evaluated the effectiveness of cognitive stimula-
tion in patients with dementia and identiﬁed nine RCTs.
Three trials that considered behaviour-related outcomes
were identiﬁed. These trials were already included in
Woods’s review133 and reached the same conclusion.
Alves et al in 2013135 (AMSTAR score=4) identiﬁed
four RCTs of cognitive interventions for AD patients.
Only one trial that measured BPSD as an outcome was
identiﬁed. The study population was composed of 32
patients with a score between 10 and 24 on the Mini
Mental State Examination, no history of antidepressant
medication and a total NPI score >5 points arising from
at least 2 domains of behaviour. The cognitive stimula-
tion intervention was administered individually and
focused on a set of tasks requiring executive functions
and working memory. The study found a statistically sig-
niﬁcant reduction of BPSD (MD −2.06; 95% CI −2.91 to
−1.21).
The study of Carrion et al in 2013136 (AMSTAR
score=4) found 17 RCTs of cognition-oriented interven-
tions (reality orientation and skills training) for demen-
tia sufferers. Challenging behaviour was evaluated in
only two trials (n=156 and n=44, respectively) that
employed the two categories of cognitive interventions,
using the NPI and the Revised Memory and Behaviour
Problems Checklist. In both RCTs, the intervention
group had a smaller increase in change from baseline
compared to the control group. Owing to the hetero-
geneity among the studies, the authors decided a
meta-analysis was inappropriate.
Yu 2009137 (AMSTAR=3) included 15 studies (9 RCTs,
5 CCTs and 1 before–after study), in addition to 5 case
studies and 3 undeﬁned studies, all of which investigated
different types of cognitive interventions for AD and
dementia. The only study, a CCT (n=32 with early-stage
AD), that evaluated the effect of cognitive stimulation
on behavioural disturbances, showed larger improve-
ment than the cognitive training group.
Olazarán et al in 2010138 (AMSTAR=4) identiﬁed 179
RCTs of diverse types of non-pharmacological interven-
tions for AD patients and examined problem behaviour,
mood, QoL, cognition, ADLs, mechanical restraint and
institutionalisation of patients and mood, psychological
well-being and QoL of CGs. The authors performed a
meta-analysis of three low-quality RCTs to determine the
effect of cognitive stimulation on problem behaviour and
mood. There was a non-statistically signiﬁcant reduction
in problem behaviour (group session cognitive stimula-
tion (ES=0.61; 95% CI 0.09 to 1.12)). The primary study
by Baines et al140 was included in the Woods133 review
above, while the study by Robichaud et al143 was included
in the review by Kim144 which examined behaviour man-
agement techniques described below.
Thirty-three RCTs, employing cognitive interventions
for cognitively impaired individuals (dementia and mild
cognitive impairment), were identiﬁed in Kurz et al145
(AMSTAR score=2). Twelve of these trials examined
behavioural disturbances, but only three studies found a
signiﬁcant effect of the intervention.
Zientz et al139 (AMSTAR score=2) identiﬁed three
studies (two RCTs and one RCT or CCT; n=124 partici-
pants) of caregiver-administered cognitive stimulation
for individuals with AD. One of the randomised trials
(n=16) found that individuals who received the interven-
tion displayed fewer behavioural problems compared to
those who had not been given the intervention.
Online supplementary etable 8 describes cognitive
stimulation-based interventions, outcomes and results of
the primary studies included in the reviews.
Reminiscence therapy
Reminiscence therapy is a non-pharmacological inter-
vention that involves the discussion of past experiences,
events and activities with family members or other
groups of people. The intervention uses materials such
as photographs, books, old newspapers and familiar
items from the past to inspire reminiscences and facili-
tate people to share and value their experiences. Three
reviews assessed reminiscence therapy as a non-
pharmacological intervention to treat agitated behaviour
in patients with dementia.29 146 147
The ﬁrst review29 received the highest score (AMSTAR
score of 6) and considered all non-pharmacological
interventions to treat relevant outcomes in patients with
dementia. The review identiﬁed two small studies involv-
ing a total of 107 patients148 149 performed in care facili-
ties. The NPI and the Clifton Assessment Procedures for
the Elderly-Behavioural Rating Scale (CAPE-BRS) were
used to measure BPSD. Seitz et al29 reported that this
outcome was unaffected in one study,149 while the effect
of the intervention was unclear in the other study.148
The second review147 was focused only on reminis-
cence therapy as a sole treatment of behavioural out-
comes for patients with dementia. The review was of low
methodological quality (AMSTAR score=3). The results
were presented in a narrative synthesis. The review
included ﬁve trials with a before–after design, contain-
ing 258 patients affected by dementia. The studies con-
sidered different interventions. Two studies (one with 31
participants (Haight 2006)150 and the other with 17 par-
ticipants (Morgan 2010151)) assessed a life review or
story approach and found signiﬁcant improvements in
depression, communication, positive mood and cogni-
tion. The third study (101 participants (Lai 2004152))
evaluated speciﬁc reminiscence, which produced a
life-story book using personalised triggers for each
person’s life history. No signiﬁcant differences were
observed between groups except for outcomes such as
well-being and social engagement. The remaining two
trials (involving 73 participants153) and 36 partici-
pants154) evaluated individual reminiscence approaches.
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One study used six weekly sessions, which focused on a
particular life phase, such as childhood or family life,
while the other study used a basket of visual and audi-
tory activities, based on ﬁve themes, such as musical
instruments, designed to stimulate reminiscence. No sig-
niﬁcant differences were observed between the groups
in terms of behavioural outcomes.
The third review146 focused on whether reminiscence
therapy could alleviate depressive symptoms in adults
with dementia, but its methodological quality was
extremely low (AMSTAR score=1). Four primary studies
with a pre–post-test design were included and were
described individually, three of which were randomised
trials and one of which comprised a single group.
Online supplementary etable 9 describes reminiscence
therapy interventions, outcomes and results of the
primary studies included in the reviews.
Validation therapy
Validation therapy is based on the general principle of
the acceptance of the reality and personal truth of
another person’s experience and incorporates a range
of speciﬁc techniques. Validation therapy is intended to
give the individual an opportunity to resolve unﬁnished
conﬂicts by encouraging and validating the expression
of feelings. The speciﬁc interventions and techniques
are based on a synthesis of behavioural and psychothera-
peutic methods. The approach can be used as a struc-
tured therapeutic activity in a group setting, usually
lasting several weeks, or it can be conducted individually
as part of an ongoing approach to facilitate communica-
tion as a supplement to group work. The validation
therapy techniques comprised non-threatening, simple
concrete words; speaking in a clear, low and empathic
tone of voice; rephrasing and paraphrasing unclear
verbal communication; responding to meanings through
explicit and implicit verbal and non-verbal communica-
tion and mirroring verbal and non-verbal
communication.
One Cochrane review that evaluated the effectiveness
of validation therapy to reduce BPSD was identiﬁed
(AMSTAR score=7).155 The review included only rando-
mised trials of participants over 65 years of age, diagnosed
with Alzheimer’s disease, dementia or other forms of cog-
nitive impairment, according to ICD 10, DSM IV or com-
parable criteria. The outcomes of interest were cognition,
behaviour, emotional state and activities of daily living.
The review, updated in 2005, included three randomised
trials (n=155 participants).156–158 Another SR159 that
evaluated the effective characteristics of residential LTC
settings for people with dementia identiﬁed one trial158
that was included in the Cochrane review.155
Primary studies
Among the primary studies, the ﬁrst study156 (n=31) was
performed in a nursing home and used an intervention
(30 min once-per-week for 6 weeks) that included activ-
ities such as discussion of a previously agreed subject,
singing and movement, followed by a closing ritual and
refreshments. Behaviour was measured with the
Behaviour Assessment Tool. The control groups con-
sisted of reminiscence therapy, which followed the guid-
ance of a reality orientation manual (cues such as
ﬂannel boards and calendars were used to promote
orientation) and usual care. At 6 weeks, validation
therapy was associated with a decrease of problem beha-
viours (MD=−5.97, 95% CI −9.43 to −2.51; p<0.001;
based on an analysis of participants who completed the
study).
The second study157 enrolled 36 patients with
moderate-to-severe disorientation of which 25 had a
diagnosis of dementia. The study was performed in a
LTC institution in the USA. The validation therapy was
performed twice-a-week for 9 months; details of the val-
idation therapy were not given. Agitation was measured
using the Minimal Social Behaviour Scale (MSBS; Farina
1957) where a reduction in score indicated improve-
ment. No effects on behaviour were detected.
The last study158 was carried out in ‘skilled-care
nursing homes’ in the USA. In this study, patients were
included if they had at least a moderate level of demen-
tia (assessed by the Short Portable Mental Status
Questionnaire—SPMSQ—and the Validation Screening
Instrument) and displayed problem behaviours, such as
physical aggression. Validation therapy (four meetings
lasting 30 min per week for 52 weeks) was composed of
groups divided into four sessions of 5–10 min each. The
ﬁrst session included introductions, salutations and
singing. The second session involved conversation
regarding a subject of interest; recalling past events was
promoted. The third session comprised an activity pro-
gramme and singing or poetry. The fourth session
involved refreshments and individual goodbyes.
Agitation was measured with the CMAI,160 carried out as
CMAI(N) nurse observed and CMAI(O) non-participant
observed. The authors reported that depression
(MOSES) decreased at 12 months (MD −4.01, 95% CI
−7.74 to − 0.28; p=0.04, based on an analysis of partici-
pants (66 out of 88) who completed the study. Online
supplementary etable 10 describes validation therapy
interventions, outcomes and results of the primary
studies included in the reviews.
Simulated presence therapy
SPT involves the use of video/audiotapes made by
family members containing scripted ‘telephone conver-
sations’ about cherished memories from earlier parts of
a person’s life, in an effort to stir remote memory,
improve behavioural symptoms and enhance the quality
of life among people with dementia.161 Two SRs were
identiﬁed.30 162
The ﬁrst review was written by only one reviewer and
scored 3 on the AMSTAR Scale. The review was aimed at
investigating the effectiveness of SPT for challenging
16 Abraha I, et al. BMJ Open 2017;7:e012759. doi:10.1136/bmjopen-2016-012759
Open Access
group.bmj.com on May 12, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
behaviours in dementia. The review searched PubMed,
PsycINFO and the Web of Science, conducted hand
searches of relevant articles and considered for inclu-
sion, studies that reported pre-test and post-test, or
pre-test and during-test data for SPT for challenging
behaviours. The SPT consisted of audio or videotapes
prepared by a spouse, family members, the caregiver, a
psychologist, a surrogate or researchers. Of the seven
included primary studies, only the data from four could
be pooled, showing an overall mean effect of 0.70, with
a 95% CI of 0.38 to 1.02, but with statistically signiﬁcant
heterogeneity (I2=71%, p=0.02).
The second review examined the efﬁcacy of any non-
pharmacological intervention (including SPT) to reduce
BPSD in patients with dementia.162 After searching the
databases MEDLINE, CINAHL, PsycINFO, EMBASE,
Dissertations International and the Cochrane Database
of Systematic Review, from 1974 to May 2008, the review
identiﬁed only two studies that were included in the
Zetteler review above.30 Online supplementary etable 11
describes SPT, outcomes and results of the primary
studies included in the reviews.
Behavioural management techniques
There is a multitude of behavioural interventions that
constitute behavioural management techniques, which
include behavioural or cognitive–behavioural therapy,
functional analysis of speciﬁc behaviour, individualised
behavioural reinforcement strategies, communication
training and other therapies such as habit training, pro-
gressive muscle relaxation and token economies. These
behavioural interventions can be realised either with the
patient or by training caregivers to perform the interven-
tion with the patient.
One overview of reviews and four SRs that considered
behavioural interventions were identiﬁed. The overview
of reviews by O’Neil 201131 identiﬁed three SRs, and
after performing additional searches of primary studies,
included nine randomised trials.163–171 The overview
authors’ conclusions were in support of behavioural
management techniques as effective interventions for
behavioural symptoms of dementia although they admit-
ted there were mixed results. In addition, the authors
highlighted some concerns regarding the variety of spe-
ciﬁc interventions and methodological limitations in
many studies and advocated additional research with
carefully assessed outcomes.
A Health Technology Assessment (HTA)172 report that
aimed to evaluate the clinical and cost-effectiveness of
sensory, psychological and behavioural interventions to
manage agitation in older adults with dementia, system-
atically searched and identiﬁed four randomised
trials.166 173–175 The intervention in all four trials was
caregiver-based. The HTA authors concluded that the
evidence in favour of the behavioural management tech-
niques was limited.
A Cochrane review176 aimed to assess the effects of
functional analysis-based interventions for people with
dementia (and their caregivers) living in their own
home or other settings and identiﬁed 18 randomised
trials. The development of the intervention was driven
by various approaches and theories, including knowl-
edge and/or training approaches, the stress-coping
model, the progressively lowered stress threshold model
and problem-solving approaches. In addition, the time
frame in which the intervention was delivered varied
from 9 days to 18 months and the number of sessions
used to deliver the intervention varied widely, from 1 to
2 sessions to more than 10 sessions. Of the 18 studies
included,164–168 173 174 177–187 the authors were able to
meta-analyse data from 4 trials,178 180 182 188 of which
one contained unpublished data. There were no signiﬁ-
cant reductions in the incidence of challenging beha-
viours reported postintervention in four family care
studies (SMD 0.02, 95% CI −0.13 to 0.17, p=0.80,
N=722).
Among 179 RCTs of diverse types of non-
pharmacological interventions for AD patients, identi-
ﬁed by Olazarán 2010138 (AMSTAR score=4), the
authors performed a meta-analysis of three low quality
RCTs of behavioural interventions (analysis and modiﬁ-
cation of antecedents and consequences of behaviour)
and found a statistically signiﬁcant reduction in problem
behaviour (ES=0.57, 95% CI 0.21 to 0.92; 3 trials;
n=167). The same authors carried out another
meta-analysis of four low-quality RCTs of care staff train-
ing in behavioural management and found a reduction
in problem behaviour (ES=0.22, 95% CI 0.02 to 0.43;
4 trials; n=370).
Two primary studies examined emotion-oriented care.
The ﬁrst study189 was a RCT of NH residents (n=146
older residents with AD, mixed AD and vascular demen-
tia and dementia syndrome; mean age 84). The inter-
vention of emotion-oriented care was associated with less
anxious behaviour in the group of residents who needed
less assistance/care compared to similar residents in the
usual care group. The second study190 was a cluster ran-
domised study of residential care homes (n=16 homes;
n=151 residents). The authors reported that there was
no statistically signiﬁcant effect of the intervention on
any behavioural outcome, including behavioural pro-
blems. Teri 2000174 was included in the HTA;172
Gormley 2001173 and Teri 2005166 were included in the
Brodaty 2012 review;191 Gonyea 2006183 was included in
reviews in behaviour management techniques and
McCallion 1999 and Teri 2005 were included in
Eggenberger 2013.192
Eggenberger 2013192 (AMSTAR score=3) aimed to
evaluate interventions that were designed to enhance
communication or interaction in dementia care, in any
setting. Review authors identiﬁed 12 studies (7 rando-
mised trials, 2 controlled clinical trials and 3 before–
after studies) that focused on communication training
for staff in institutions and family caregivers at home. In
institutional settings, the results on challenging behav-
iour, of residents with dementia, were not consistent.
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Four studies reported a signiﬁcant reduction of challen-
ging behaviour.171 193 194 McCallion et al,171 for instance,
demonstrated a decrease of physically aggressive behav-
iour (15.16 (SD 9.81) to 12.21 (SD 8.31), p<0.001)) and
a reduced mean occurrence of verbally aggressive behav-
iour in patients with dementia (16.22 (SD 10.31) to
12.88 (SD 8.39), p<0.001)). In addition, one trial demon-
strated a signiﬁcant decrease of residents’ agitation
during care routines (F(1.7=5.12, p<0.05)).194 Conversely,
three studies reported no effect on challenging behaviour
of people with dementia.195–197 Only one trial167 was
included in the Brodaty 2012 review.191
Kim et al144 conducted a review to assess the effective-
ness of occupational therapy on behavioural problems
and depression in patients with dementia. MEDLINE,
CINAHL, ProQuest and The Cochrane Library were
searched up to the end of March 2011. The AMSTAR
score was 7. The authors deﬁned occupational therapy
as an application of ‘activity analysis, caregiver training,
sensory stimulation, behaviour control skill teaching,
physical and social environmental modiﬁcation, cogni-
tive training, and purposeful activity’. The review identi-
ﬁed nine randomised trials with a total of 751
participants. On the basis of the type of intervention,
the authors categorised four studies118 120 143 198 as
sensory stimulation, three studies198–200 as functional
task activities and two studies200 201 as environmental
modiﬁcation. The authors performed a meta-analysis of
the trials with occupational therapy-based sensory stimu-
lation and found an ES of 0.32 (95% CI 0.04 to 0.59;
250 participants; no signiﬁcant heterogeneity). No sig-
niﬁcant effect was detected for OT-based functional task
activities (0.15, 95% CI −0.17 to 0.47; 203 participants)
or environmental modiﬁcation (0.13, 95% CI −0.09 to
0.36; 298 participants).
Primary studies
Overall 22 trials were evaluated in the 6 reviews that
were included. Except for one study performed in
Taiwan, all the studies were carried out in Europe, the
USA and Australia. Thirteen studies were performed in
family care settings.164 167 168 173 174 178 180 182–187 Three
studies with a total of 740 residents were conducted in
care homes.165 179 181 Finally, one study was located in
an assisted living setting166 and the other in a hospital
setting.177
Characteristics of the interventions varied greatly
across the trials. Fifteen trials were focused on enhan-
cing communication skills in family and formal care-
givers. Eighteen trials focused on functional activity of
which four were described as a behavioural management
intervention. The intervention in one trial involved care-
giver training on verbal or non-verbal communication
focused on activities of daily living. Another trial was
dedicated to teaching participants the basic technique
for progressive muscle relaxation.170 Time delivery of
the intervention also varied widely. However, as noted by
Moniz-Cook, the intervention delivery was determined
by setting: the interventions in care homes were pro-
vided weekly and lasted for 6 months.176 In one family
care study, the intervention was provided in just 4 ses-
sions over 8 weeks.173 Follow-up data varied from a few
weeks to 24 months.
Setting-based description
Family care: In this setting, family caregivers assisted
people with dementia at home, with or without support
from formal caregivers, healthcare workers and adult
day care centres. Thirteen trials were conducted in a
family care setting.164 166 168 173 174 176 178 180 182–185
187 200 201
Six of these trials investigated an intervention that was
focused on enhancing communication skills of the care-
giver. The duration of the intervention ranged from 3
weeks184 to 12 months.178 The number of weekly sessions
administered were, according to a classiﬁcation pro-
posed by Moniz-Cook 2012,176 high (>10 session) in
three trials,164 178 180 185 moderate-high (6–10 sessions)
in one trial,185 moderate (3 to 5 sessions) in one trial182
and minimal (1 to 2 sessions) in one trial.184 The partici-
pants who delivered the interventions varied from trial
to trial: occupational therapists;182 trained nurses or
social workers;180 professionals specialised in the
REACH programme;178 healthcare professionals super-
vised by an old age psychologist;164 psychologists185 or
trial investigator together with an experienced nurse.184
Of the 13 trials in the family care setting, 4 investi-
gated a behavioural intervention that was focused on
providing support to the caregiver. The interventions
lasted from 5 weeks183 to 18 months,186 with the number
of sessions that varied from 4186 to 8 sessions,187 with
home visits176 187 and associated with or followed by tele-
phone contacts.166 168 Overall, the intervention dosage
was high for three trials,166 168 176 medium-high in one
trial187 and moderate in one trial.183 The interventions
were delivered by different healthcare experts: commu-
nity mental health nurses;176 therapists;187 occupational
therapists;168 community consultants trained by an old
age psychologist.166
The remaining two trials evaluated behavioural man-
agement techniques. Teri 2000174 compared the inter-
vention consisting of eight weekly and three biweekly
sessions (high-intensity intervention) with pharmaco-
logical interventions or placebo. The intervention was
provided by a therapist with a master’s degree and 1-year
clinical experience, but was not reported in detail. The
postintervention evaluation started at 4 months, and the
follow-up lasted beyond 12 months. The second study173
did not completely describe the intervention for behav-
ioural management. The intervention was delivered in
four sessions (moderate intensity) over 8 weeks by the
trial investigator.
In terms of results, no statistically signiﬁcant change in
the incidence of challenging behaviours was observed in
any of the studies. Moniz-Cook 2012 meta-analysed data
of four studies (N=722), but did not ﬁnd any difference
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among the groups (SMD 0.02, 95% CI −0.13 to 0.17,
p=0.80; I2=0%).168 178 180 182 At follow-up of 6 months,
two studies did not show any signiﬁcant effect of behav-
ioural management techniques.168 180
When the frequency of challenging behaviours was
examined, none of the studies detected a signiﬁcant dif-
ference even when a meta-analysis, using the data from
10 studies, was performed (SMD −0.05, 95% CI −0.17 to
0.07).
Assisted living: In this setting, people with dementia
lived in a residence, did not require full-time nursing
care, but needed assistance with some ADLs, such as
bathing, dressing and eating. Family members could still
act as intermittent caregivers during visits by providing
different types of support for ADLs, instrumental ADLs
(eg, laundry washing, room cleaning, transportation to a
doctor’s ofﬁce), socioemotional support (eg, talking,
reminiscing, socialising), monitoring care provision or
advocating.202 One study evaluated a behavioural man-
agement intervention to improve caregiver training to
manage residents with dementia.166 The intervention
intensity was medium-high, delivered by a clinical psych-
ologist and graduate nursing students who performed
two half-day group workshops and four individualised
sessions with a follow-up 2 months after the termination
of the intervention. Results for residents showed a statis-
tically signiﬁcant effect, in intent-to-treat analyses, in
favour of the STAR-caregivers (STAR-C) intervention,
general behavioural disturbance (measured by the
Revised Memory and Behaviour Problems Checklist
(RMBPC), NPI and ABID) and depression.
Residential care: This setting referred to assisted living
residences and nursing homes. The latter included facil-
ities for people with dementia who needed signiﬁcant
nursing care. Three cluster randomised trials were con-
ducted in residential care with a total of 743
residents.165 179 181
In 15 residential care sites across metropolitan areas in
Sydney (Australia), Chenoweth et al179 examined the efﬁ-
cacy of person-centred care versus usual care. The inter-
vention was a high-intensity, person-centred care, based
on the needs-driven model in which staff, selected by
managers, administered training sessions to caregivers.
The topics covered during the sessions were derived
from Bradford University’s training manual. The dur-
ation of the intervention was 4 months, and the overall
follow-up was 8 months. The total number of residents
enrolled was 289. During follow-up, the mean agitation
score (measured with the CMAI) in the person-centred
care group decreased signiﬁcantly, from 47.5 (9.1) at
baseline, to 37.2 (9.1) at 6 months (p=0.01), compared
to usual care in which agitation increased from 50.3
(6.8) at baseline to 57.7 (6.8) at 6 months (p value not
reported).
In 12 residential homes, Fossey 2006181 allocated 346
residents to an intervention that consisted of training
and support delivered to nursing home staff over
10 months, focusing on person-centred care and skill
development for the management of agitated behaviour
in dementia. The comparison intervention was usual
care. The high-intensity intervention was delivered
during the whole period of follow-up (12 months) by a
psychologist, an occupational therapist or a nurse super-
vised weekly by the trial investigators. The study’s main
outcome measure was mean levels of agitated and dis-
ruptive behaviour measured with the CMAI, but no sig-
niﬁcant difference between the groups was detected.
In 10 residential homes, Proctor 1999165 allocated
120 patients to a staff-based intervention or usual
care. The intervention, of high-medium intensity, con-
sisting of training on “psychosocial management of
residents’” behavioural problems, was delivered
through seven, 1-hour seminars by members of the
hospital outreach team and psychiatric nurse during
the whole period of follow-up (6 months). The semi-
nars covered topics that the staff had identiﬁed to
improve their knowledge and skills (eg, management
of dementia, aggression, etc). The Crichton Royal
Behavioural Rating Scale was used to assess behav-
ioural characteristics of residents (0=no problems,
38=severe problems). In addition, the geriatric mental
state schedule and the diagnostic algorithm AGECAT
(Automatic Geriatric Examination for
Computer-Assisted Taxonomy) were used to assess the
effect of the intervention on residents’ organic and
depressive symptoms. Despite the control group
having mean scores on the Crichton Scale higher
than the intervention group at follow-up, this differ-
ence was not statistically signiﬁcant (mean score −0.7
(−3.0 to 1.6)).
Although the clustered trials reported different types
of interventions, intensities, durations and follow-up
times, Moniz-Cook et al176 attempted an analysis using
two studies and found a signiﬁcant reduction in behav-
ioural disturbances (SMD, −0.21, 95% CI −0.39 to
−0.03; p=0.02; I2=9%).
Online supplementary etable 12 describes behavioural
management technique-based interventions, outcomes
and results of the primary studies included in the
reviews.
Multicomponent interventions
Integrated interventions combining psychiatric and nursing
home care
Collet 2010203 (AMSTAR score=5) carried out a SR in
MEDLINE, PsycINFO and PubMed to determine the
efﬁcacy of interventions that combined psychiatric and
nursing home care in nursing home residents. The
authors identiﬁed 4 RCTs (n=371 participants), 1 retro-
spective cohort study and 3 prospective case studies. All
the studies used tailored treatment plans that combined
psychosocial, nursing, medical and pharmacological
interventions. The results of the RCTs were described
narratively. Three out of the four randomised trials
reported an improvement in behaviour and mood, while
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one trial found no difference among the groups (online
supplementary etable 13).
Combination of environmental sensory stimulation
A SR204 that evaluated the effective characteristics of resi-
dential LTC settings for people with dementia identiﬁed
one controlled clinical trial.205 The intervention in this
trial was provided in ﬁve nursing homes and consisted of
15 agitated participants with dementia taking showers, 15
agitated participants with dementia taking walks in an
environment where natural elements such as large
bright pictures coordinated with audio, including bird
songs, bird pictures, the sound of water ﬂowing gently, as
well as food (such as banana, pudding and soda). The
control group consisted of 15 other agitated participants
with dementia that received only usual care. Agitation
was measured with a modiﬁed version of CMAI. The ana-
lysis showed a signiﬁcant decline in agitation in the treat-
ment group with respect to the comparison group.
Combination of music and hand massage
Another review72 that aimed to assess the role of physical
environment in supporting person-centred dining in LTC
identiﬁed another trial206 that was not included in the
previous reviews. This trial applied an experimental 3×3
repeated measures design and included 41 residents with
dementia living in three SCUs. Participants were mostly
women (78.0%), with a mean age of 84.5 years (SD=6.0).
Residents in the treatment group received each of three
treatments (hand massage, favourite music and the com-
bination of both) with each treatment lasting 10 min; the
control group did not receive any treatment. The CMAI
was used to measure agitation. The results showed that
each single and combined treatment were effective in sig-
niﬁcantly decreasing agitation immediately following the
intervention and one-hour postintervention.
Online supplementary etable 13 describes multicom-
ponent interventions, outcomes and results of the
primary studies included in the reviews.
Other interventions
Exercise therapy
The systematic search identiﬁed two reviews207 208 that
evaluated the efﬁcacy of only exercise as a therapeutic
intervention.
The review by Potter et al207 received 6 points in the
AMSTAR assessment and identiﬁed 13 randomised trials
that evaluated the effects of physical activity on physical
functioning, quality of life and depression in older
people with dementia. Only four of these trials investi-
gated depression as an outcome using four different
rating scales (Geriatric Depression Scale (GDS15);
Montgomery-Asberg Depression Rating Scale (MADRS);
a Dutch Evaluation scale for older patients (subscale
used) and the CSDD) and two trials measured behav-
ioural disturbances (NPI and Stockton Geriatric Rating
Scale).
The review authors stated that the methods of ran-
domisation were clear and adequate in six of the trials
with only three of these also providing methods of allo-
cation concealment; eight of the trials reported informa-
tion regarding losses to follow-up and six trials declared
intention-to-treat analysis.
The ﬁrst study, Burgener 2008,209 was a small trial
(n=43) carried out in community-dwelling older people
with dementia. The intervention was multimodal com-
prising Tai Chi (sitting and standing; 60 min, 3
times-a-week for 40 weeks) and cognitive–behavioural
therapies. Depressive symptoms were measured with the
GDS15. The authors reported that at 20 weeks of obser-
vation, there were no statistical differences between the
groups.
The second study, Rolland 2007,210 was a larger trial
(n=134) carried out in nursing homes. Participants per-
formed exercises including stretching, walking, strength,
ﬂexibility and balance training for 60 min, 2 times/week
for 40 weeks. Depression was evaluated using the
MADRS. After 12 months of observation, the MADRS
score (13.4±8.0) was higher in the intervention group
than in the control group (14.8±7.2), but without any
statistical difference.
The third study103 was also a small study (n=25) con-
ducted in a psychiatric hospital. The invention was com-
posed of strength, balance and ﬂexibility exercises with
music, 30 min daily for 12 weeks. Depression was mea-
sured in older patients with the subscale Beoordelingsschaal
voor Oudere Patienten. At 3 months follow-up, no signiﬁ-
cant difference in depressive behaviour was observed.
The last study164 was a larger trial (n=153) that
enrolled community-dwelling patients and their care-
givers. The exercise intervention, for patients, comprised
aerobic, endurance, strength, balance and ﬂexibility
training, 30 min twice weekly, reducing to twice monthly,
for 23 weeks. Caregivers were given training in behav-
ioural management techniques. The CSDD was used to
assess depression. At a 2-year follow-up, the mean differ-
ence was 2.14 (95% CI 0.14 to 4.17) and statistically sig-
niﬁcant in favour of the intervention. The four trials
used different types of interventions, outcome measures
and follow-up times that hindered the possibility of per-
forming meta-analyses.
The two randomised trials103 210 that considered
behavioural disturbances used the NPI and Stockton
Geriatric Rating Scale, respectively.
The second review by Thuné-Boyle et al208 received an
AMSTAR score of 2 and included six studies comprising
two small randomised trials (n=31), two prospective
design and two repeated measures studies that examined
the effect of exercise on BPSD. In the ﬁrst trial
(Hokkanen 2003), the exercise intervention consisted of
16 sessions of dance and rhythmic movement lasting 30–
45 min, once-a-week. This trial was already discussed in
the dance section. The second trial211 aimed to assess
the efﬁcacy of a home-based exercise intervention pro-
gramme to improve the functional performance of
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patients with AD. The intervention consisted of a daily
programme of aerobic, balance and ﬂexibility and
strength training, given to patients and caregivers.
Depression and apathy were measured using NPI and
the CSDD at 6 and 12 weeks. Online supplementary
etable 14 describes exercise therapy, outcomes and
results of the primary studies included in the reviews.
Animal-assisted therapy
One review212 performed a comprehensive literature
search in PubMed, EMBASE and PsycINFO to identify
pertinent studies that evaluated the efﬁcacy of animal-
assisted therapy (AAT) in older patients with dementia
or other psychiatric disorders. The authors identiﬁed 23
eligible studies of which 18 recruited patients with
dementia, but only 10 studies investigated the effect of
AAT on BPSD. The design of the studies was as follows:
3 case–control and 7 repeated measures (eg, interrupted
time series analysis) studies. Overall, the authors con-
cluded that AAT may have positive inﬂuences on
patients with dementia by reducing the degree of agita-
tion and improving the amount and quality of social
interaction. However, they advocated more research
examining the issue of optimal AAI duration, frequency
of sessions and suitable target group.
Primary studies
Churchill et al213 included 28 residents of three SCUs
with dementia (25% women; mean age 83.8 years;
dementia evaluated with Bourke Dementia Rating
Scale). The authors administered pet-therapy visits
during the difﬁcult ‘sundown’ time to examine the
effect on residents with a history of agitated ‘sundown-
ing’ behaviour. The active group was exposed to 30-min
interaction with an investigator and a dog, which amelio-
rated agitated/aggressive behaviour measured with the
Agitated Behaviours Mapping Instrument Scale.
However, the study did not report the p values. In addi-
tion, the variability in resident response over time after
the departure of the dog was not explored.
The effect of dog-based AAT was also evaluated in
another special care unit. McCabe et al214 enrolled 22
participants with dementia (women 68%; mean age
83.7, range 68–96 years). The study introduced a resi-
dent dog and agitated behaviour was measured using
the Nursing Home Behaviour Problem Scale. Data were
collected 1 week before and for the ﬁrst 4 weeks after
introduction of the dog. The authors reported a signiﬁ-
cant reduction in daytime behavioural disturbances
among residents, but not during evening shift.
In a small pilot study, Richeson215 evaluated visiting
therapy dogs in 15 residents with dementia (14 women;
age range 63–99 years; dementia MMSE mean score: 3.9;
26% with depression). The session with visiting therapy
dogs lasted 1 hour daily for 3 weeks. Agitated behaviour,
measured with the CMAI, decreased signiﬁcantly after
3 weeks and increased signiﬁcantly after 2 weeks washout
subsequent to the end of AAT.
Libin and Cohen-Mansﬁeld216 assessed the efﬁcacy of
a robotic cat (NeCoRo) and a soft toy cat in reducing
agitated behaviour in nine women with moderate
dementia in nursing homes. The intervention consisted
of two, 10-min interactive sessions on different days. The
robotic cat produced a signiﬁcant increase in pleasure
and interest, but did not reduce agitation. Conversely,
the soft toy cat signiﬁcantly reduced agitation.
Motomura et al217 included 8 women (mean age
84.8 years) residing in a nursing home and evaluated
the efﬁcacy of AAT, consisting of two dogs visiting for
1 hour, over four consecutive days, to reduce apathy or
irritability. The outcomes were measured using the
Geriatric Depression Scale, Physical Self-Maintenance
Scale and MMSE. The intervention did not show any sig-
niﬁcant change on any of the outcomes evaluated.
Sellers et al218 included four residents with dementia to
evaluate the efﬁcacy of a visiting dog. Agitation was mea-
sured with the Agitated Behaviours Mapping Instrument
and Social Behaviour Observation Checklist. The authors
reported that the intervention reduced agitated behav-
iour during treatment and increased observed social
behaviour, but data and p values were not reported.
Dining room environment
Two small (n=38) pre-post studies included in Whear’s
review85examined the effect of improved lighting and
table-setting contrast in a dining room environment.
One study219 (Brush 2002; n=25) found a positive effect
on problem behaviours using the Meal Assistance
Screening Tool, while the other study220 found a statisti-
cally signiﬁcant reduction in daily agitation.
Special care units
In a Cochrane review, Lai 2009 (AMSTAR=8) examined
SCUs for dementia individuals with behavioural pro-
blems. SCUs are characterised by trained staff, special
care programmes, an altered physical environment and
involvement of families. This SR included one
quasi-experimental study and seven observational studies
(six prospective cohort studies and one prospective case–
controlled study). The absence of randomised trials is
likely a consequence of important practical and ethical
issues in applying this methodology in older participants
with dementia and behavioural problems. Only one case-
controlled study evaluated agitation and used NPI and
CMAI to measure the outcome in 65 participants with
dementia.221 The results showed no signiﬁcant changes
in outcomes at 3 months; however, there were small, but
signiﬁcant improvements in the NPI score in favour of
the SCU group at 6 months (WMD −4.30 (95% CI −7.22
to −1.38), 12 months (WMD −4.30 (95% CI −7.22 to
−1.38)) and 18 months (WMD −5.40 (95% CI −9.16 to
−1.65)). The same study also evaluated the effect of SCU
on mood at 3 months, and the results showed a small sig-
niﬁcant effect in favour of SCU (WMD −6.30 (95% CI
−7.88 to −4.72)).221
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DISCUSSION
Given the well-known negative side effects of commonly
prescribed drugs to control behavioural disturbances
(BPSD) in patients with dementia, non-pharmacological
interventions have gained increasing attention in recent
years as an alternative ﬁrst-line approach to treat BPSD.
This overview addresses the evidence supporting the efﬁ-
cacy of these interventions in community and residential
care settings. We identiﬁed a number of SRs, which
often focused on single interventions although, in
several instances, multicomponent interventions were
also examined. With the present study, using the
primary studies included in the SRs, we have created a
compendium of the types of non-pharmacological inter-
ventions, including the component of each single inter-
vention, the dosage (when available) and the duration
of the treatment.
In the absence of a validated taxonomy, we categorised
the interventions according to the following classiﬁca-
tion: sensory stimulation interventions; cognitive/
emotion-oriented interventions; behaviour management
techniques (further subdivided according to the recipi-
ent of the intervention, ie, the person with dementia,
the caregiver or the staff); multicomponent interven-
tions and other interventions, such as exercise and
animal-assisted therapies.
Among sensory simulation interventions, the only
convincingly effective intervention for reducing behav-
ioural symptoms (speciﬁcally agitation and aggressive
behaviour) was music therapy. According to the most
comprehensive review of music therapy, this treatment
also reduced anxiety. However, the evidence supporting
the effectiveness of music therapy was limited by mod-
erate, but signiﬁcant, heterogeneity, probably related to
the variability of the intervention (eg, type of music,
active involvement, such as singing/playing a musical
instrument and dancing, or passive involvement, such
as listening) and the heterogeneity of the patient popu-
lation in terms of the severity of dementia and the
type of dementia. The efﬁcacy of aromatherapy and
massage therapy, both associated with conﬂicting
results, remains unknown. Light therapy and SMST
therapy did not show any noteworthy effect for clinical
practice.
The body of evidence concerning cognitive/emotion-
oriented interventions, which include reminiscence therapy,
SPT and validation therapy, had important methodological
limitations. The quality of the primary studies was low, as
reported by the review authors, and the sample size of
the studies was not powered to detect statistically signiﬁ-
cant effects. Even when it was possible to combine
studies in a meta-analysis, for example, for SPT, the
pooled estimated effect was not statistically signiﬁcant.
Added to these shortcomings was the variability in the
length and type of the interventions and the multitude
of outcomes measured. Overall, convincing evidence
supporting the effectiveness of these psychological inter-
ventions was lacking.
The most frequently assessed intervention in several
trials was behavioural management techniques. The ele-
ments in this type of intervention included behavioural
or cognitive–behavioural therapy, functional analysis of
speciﬁc behaviour, individualised behavioural reinforce-
ment strategies, communication training and other ther-
apies, such as habit training, progressive muscle
relaxation and token economies.31 The body of evidence
supporting the effectiveness of behavioural management
techniques includes positive and negative studies.
Among the types of behavioural management techni-
ques which aimed to enhance communication skills,
formal caregiver training and dementia mapping pro-
vided in residential care were found to be effective at
reducing agitation. The evidence was convincing when
the intervention was supervised by healthcare profes-
sionals, with the effectiveness possibly persisting for
3–6 months.
There is some evidence that multicomponent inter-
ventions that use a comprehensive, integrated multidis-
ciplinary approach combining medical, psychiatric and
nursing interventions can reduce severe behavioural pro-
blems in nursing home patients.
Other interventions such as animal-assisted and exer-
cise therapy did not show any convincing effect on any
BPSD.
Strengths of this overview
The present overview represents a substantial update of
a previous overview,31 using a search strategy launched
in 2009, that provided a comprehensive synthesis of the
evidence about non-pharmacological interventions on
BPSD. We systematically searched reviews available in
four electronic databases and systematically collected the
evidence regarding non-pharmacological interventions
for the treatment of behavioural disturbances in patients
with dementia. To allow the identiﬁcation of SRs of all
potential non-pharmacological interventions, we used a
highly sensitive search strategy by avoiding the inclusion
of any speciﬁc name of non-pharmacological interven-
tions. We also assessed the methodological quality of the
reviews using the AMSTAR criteria. Another strength of
the present overview was the adoption of a systematic
and transparent method, and the use of duplicate, inde-
pendent reviewers who performed the phases of study
selection, data abstraction and data interpretation
separately.38
Limitations of the interpretation of the results
Overall, the SRs had a number of methodological limita-
tions that could have affected the conﬁdence in the
reported results. First, the heterogeneity of the types
and characteristics of the interventions, even within the
same class of non-pharmacological interventions, was
the most signiﬁcant problem that emerged from the
present study. One implication is that there are serious
methodological issues that question the correctness, in
our opinion, of combining studies in a meta-analysis, as
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some authors have previously performed. Moreover, in
some studies, the description of the interventions is too
vague to allow a complete understanding of what was
actually performed. In addition, even in cases in which
the intervention is well characterised, the dosage of the
intervention, and the means used for its delivery, varied
considerably. For example, in the case of music therapy,
music interventions such as listening to music via head-
phones, based on participants’ musical preferences,87
differed from listening, playing percussion instruments,
singing, movement or dance86 and was observed across
all nine trials combined in the meta-analysis. In the case
of aromatherapy, there were several essential oils that
were used in the primary studies, but in some instances,
even when similar components were used (eg, Melissa
essential oil), the mode of administration differed
among trials. Similarly, there was great variation in the
intensity (from 2500 to 10 000 lux), duration (1–
9 hours), frequency of exposure (10 days to 10 weeks)
and type of device used (Dawn-Dusk Simulator222),
when light therapy was investigated for behavioural pro-
blems in dementia.
The variation in the characteristics of the interven-
tions was particularly pronounced in the trials ascribed
to behavioural management techniques. The trials used
different conceptual frameworks, and sometimes broad
and quite generic descriptions, to describe the interven-
tions that at times were difﬁcult to interpret and which
inﬂuenced the content and quality of evidence of the
SRs. In this area, it is therefore difﬁcult to produce a
satisfactory classiﬁcation, which implies that different
SRs did not consider the same group of studies, even
when they clearly investigated non-pharmacological
interventions speciﬁcally designed to improve behav-
ioural management.
Finally, the arbitrary age cut-off of the patients (more
than 60 years of age) and the exclusion of reviews pub-
lished before 2009 constitute other limitations of the
present overview. We did not evaluate the methodo-
logical quality of the primary studies included in the
reviews, as this will be the scope of our next publication,
in which we will apply the GRADE criteria.38
CONCLUSION
This overview succeeded in providing a complete and
up-to-date compendium of non-pharmacological inter-
ventions in older people with dementia, using recently
published SRs and meta-analyses. The most promising
treatments appeared to be music therapy and some
behavioural management techniques, particularly
those involving caregiver-oriented and staff-oriented
interventions. Despite the considerable number of
published articles included in this overview, the evi-
dence supporting the efﬁcacy of non-pharmacological
interventions is limited due to methodological quality
and sample size and to the presence of important var-
iations in the taxonomy of the non-pharmacological
interventions, the outcomes assessed and the tools
used to evaluate the outcomes.
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